Edition:
United States

Citius Pharmaceuticals Inc (CTXR.OQ)

CTXR.OQ on NASDAQ Stock Exchange Capital Market

1.07USD
23 Aug 2019
Change (% chg)

-- (--)
Prev Close
$1.07
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
21,667
52-wk High
$2.52
52-wk Low
$0.86

Latest Key Developments (Source: Significant Developments)

Citius Pharmaceuticals Inc Files For Sale Of Up To 3.67 Mln Shares Of Common Stock
Wednesday, 17 Apr 2019 04:59pm EDT 

April 17 (Reuters) - Citius Pharmaceuticals Inc ::CITIUS PHARMACEUTICALS INC FILES FOR SALE OF UP TO 3.67 MILLION SHARES OF COMMON STOCK, BY THE SELLING STOCKHOLDERS - SEC FILING.  Full Article

Citius Pharmaceuticals Provides Updates On Mino-Lok & Citi-002
Wednesday, 19 Dec 2018 09:45am EST 

Dec 19 (Reuters) - Citius Pharmaceuticals Inc ::CITIUS PHARMACEUTICALS PROVIDES UPDATES ON MINO-LOK AND CITI-002.CITIUS PHARMACEUTICALS INC - CITIUS HAS SECURED PATENTS FOR MINO-LOK IN BOTH U.S. AND EUROPE THAT PROTECT PRODUCT THROUGHOUT YEAR 2036.CITIUS PHARMACEUTICALS INC - WILL BE PURSUING A PATENT FOR CITI-002.  Full Article

Myron Holubiak Reports 12.6 Pct Stake In Citius Pharmaceuticals
Monday, 27 Aug 2018 04:18pm EDT 

Aug 27 (Reuters) - Myron Z Holubiak::MYRON Z HOLUBIAK REPORTS 12.6 PERCENT STAKE IN CITIUS PHARMACEUTICALS AS OF AUGUST 13 - SEC FILING.MYRON Z HOLUBIAK SAYS OBTAINED SHARES OF COMMON STOCK, WARRANTS TO BUY COMMON STOCK OF CITIUS PHARMACEUTICALS FOR 'INVESTMENT PURPOSES'.  Full Article

Citius Pharmaceuticals Successfully Raises $10 Million
Wednesday, 15 Aug 2018 08:00am EDT 

Aug 15 (Reuters) - Citius Pharmaceuticals Inc ::CITIUS PHARMACEUTICALS SUCCESSFULLY RAISES $10 MILLION.CITIUS PHARMACEUTICALS - INTENDS TO USE CAPITAL FROM RAISE TOWARDS PHASE 3 CLINICAL MINO-LOK TRIAL FOR TREATING CATHETER RELATED BLOODSTREAM INFECTIONS.CITIUS PHARMACEUTICALS - INTENDS TO USE CAPITAL FROM RAISE TOWARDS PHASE 2B CLINICAL TRIAL OF CITI-002 FOR SYMPTOMATIC TREATMENT OF HEMORRHOIDS.  Full Article

Citius Pharmaceuticals To Sell Up To 1.4 Mln Shares Of Co's Common Stock
Friday, 20 Apr 2018 05:03pm EDT 

April 20 (Reuters) - Citius Pharmaceuticals Inc ::CITIUS PHARMACEUTICALS - TO SELL OR OTHER DISPOSITION FROM TIME TO TIME OF UP TO 1.4 MILLION SHARES OF CO'S COMMON STOCK.  Full Article

Citius Announces $6 Mln Registered Direct Offering Priced At-The-Market
Monday, 18 Dec 2017 08:00am EST 

Dec 18 (Reuters) - Citius Pharmaceuticals Inc ::CITIUS ANNOUNCES $6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET.CITIUS PHARMACEUTICALS - ENTERED AGREEMENTS WITH SEVERAL INSTITUTIONAL, ACCREDITED INVESTORS TO BUY 1.3 MILLION SHARES AT $4.6925/SHARE.  Full Article

Citius Pharmaceuticals Says On Nov 27, Board Appointed Jaime Bartushak As CFO And Principal Financial Officer Of Co
Friday, 1 Dec 2017 05:14pm EST 

Dec 1 (Reuters) - Citius Pharmaceuticals Inc ::CITIUS PHARMACEUTICALS INC - ‍ON NOV 27, , BOARD APPOINTED JAIME BARTUSHAK AS CFO AND PRINCIPAL FINANCIAL OFFICER OF COMPANY, EFFECTIVE NOV. 27, 2017​.  Full Article

Citius Pharmaceuticals files for mixed shelf offering of up to $50 mln - SEC filing‍​
Thursday, 9 Nov 2017 05:46pm EST 

Nov 9 (Reuters) - Citius Pharmaceuticals Inc :Citius Pharmaceuticals Inc - files for mixed shelf offering of up to $50 million - SEC filing‍​.  Full Article

Citius pharmaceuticals receives "fast track" designation by FDA for mino-lok™ investigational trial
Tuesday, 31 Oct 2017 08:00am EDT 

Oct 31 (Reuters) - Citius Pharmaceuticals Inc :Citius Pharmaceuticals, Inc. Receives "fast track" designation by FDA for mino-lok™ investigational trial.  Full Article